Evidence map›Paper›PMID 20809047›Full record

ArticleMolecular medicine (Cambridge, Mass.)

A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis.

Gustavo A Nader, Maryam Dastmalchi, Helene Alexanderson, Cecilia Grundtman, Ramkishore Gernapudi, Mona Esbjörnsson, Zuyi Wang, Johan Rönnelid, Eric P Hoffman, Kanneboyina Nagaraju and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 104 citations in OpenAlex.

  1. Strength training and aerobic exercise training for muscle disease.The Cochrane database of systematic reviews · 2019
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Exercise in Myositis.Current treatment options in rheumatology · 2018
    Review
  19. Review
  20. Selected aspects of the current management of myositis.Therapeutic advances in musculoskeletal disease · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Gustavo A NaderResearch Center for Genetic Medicine, Children's National Medical Center, Washington, DC, USA.
Maryam Dastmalchi
Helene Alexanderson
Cecilia Grundtman
Ramkishore Gernapudi
Mona Esbjörnsson
Zuyi Wang
Johan Rönnelid
Eric P Hoffman
Kanneboyina Nagaraju
Ingrid E Lundberg
Children's National · USKarolinska Institutet · SEKarolinska University Hospital · SEUppsala University Hospital · SE

Funding

NCMRR-DC Core Molecular & Functional Outcome Measures in Rehabilitation MedicineR24HD050846 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI KNOBLACH, SUSAN M · 2005 to 2014
$8.6M
Wellstone Muscular Dystrophy Center: Children's Nat'l Med CtrU54HD053177 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI HOFFMAN, ERIC P. · 2005 to 2009
$7.3M
Improved Diagnostic of the Muscular DystrophiesR01NS029525 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOFFMAN, ERIC P. · 1991 to 2015
$6.5M
Pathogenesis of autoimmune myositis: Role of MHC Class 1R01AR050478 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI NAGARAJU, KANNEBOYINA · 2005 to 2009
$1.9M
NIAMS NIH HHS R01 AR050478NIAMS NIH HHS R01-AR050478NICHD NIH HHS 1U54HD053177NICHD NIH HHS 5R24HD050846NICHD NIH HHS R24 HD050846NICHD NIH HHS U54 HD053177NINDS NIH HHS 3R01-NS29525-13NINDS NIH HHS NS-029525NINDS NIH HHS R01 NS029525
6 · The paper itself

Abstract

Polymyositis and dermatomyositis are orphan, chronic skeletal muscle disorders characterized by weakness, infiltrations by mononuclear inflammatory cells, and fibrosis. Until recently, patients were advised to refrain from physical activity because of fears of exacerbation of muscle inflammation. However, recent studies have shown that moderate exercise training in combination with immunosuppressive drugs can improve muscle performance. Despite the positive effects of exercise training, the molecular mechanisms underlying the exercise-associated clinical improvements remain poorly understood. The present study was designed to define, at the molecular level, the effects of resistance exercise training on muscle performance and disease progression in myositis patients. We evaluated changes in muscle strength, histology and genome-wide mRNA profiles to determine the beneficial effects of exercise and determine the possible molecular changes associated with improved muscle performance. A total of 8 myositis patients underwent a 7-wk resistance exercise training program that resulted in improved muscle strength and increased maximal oxygen uptake (VO(2max)). Training also resulted in marked reductions in gene expression, reflecting reductions in proinflammatory and profibrotic gene networks, changes that were also accompanied by a reduction in tissue fibrosis. Consistent with the exercise-associated increase in VO(2max), a subset of transcripts was associated with a shift toward oxidative metabolism. The changes in gene expression reported in the present study are in agreement with the performance improvements induced by exercise and suggest that resistance exercise training can induce a reduction in inflammation and fibrosis in skeletal muscle.

Indexed as

Gene Expression ProfilingMuscle StrengthResistance TrainingAdultFibrosisGlucocorticoidsHumansImmunosuppressive AgentsInflammationLongitudinal StudiesMiddle AgedMuscle, SkeletalMyositisOxygen ConsumptionRNA, MessengerGlucocorticoidsImmunosuppressive AgentsRNA, Messenger

Identifiers

PMID20809047
PMCPMC2972393
OpenAlexW109924101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.